Business · 29/10/2004

National Institutes of Health to Consider Exclusive License for Dengue Vaccine

The National Institutes of Health is issuing a notice of its intention to grant an exclusive license for a dengue vaccine that contains a specific 30-nucleotide deletion in the 3'-UTR of dengue types 1, 2, 3, and 4, as outlined in several patent applications.